- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03431233
Effect of Premeal Protein-bar on Food Intake
August 28, 2019 updated by: Young Min Cho, Seoul National University Hospital
An Exploratory Study of the Effect of Premeal Consumption of Protein-enriched, Dietary Fiber-fortified Cereal Bar on Food Intake in Healthy Subjects
The aim of this study is to explore premeal protein-enriched bar effect in food intake in healthy subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Twenty healthy subjects will be recruited.
Every subject will be randomized in 6 groups and studied on 3 separate days in random order with 1 week intervals.
These participants will consume protein enriched bar, commercial cereal bar, or water followed by a standardized diet (gimbap).
For study outcomes, food intake, appetite and satiety (visual analog scale), plasma glucose, and satiety related hormone will be measured.
Blood sampling will be done before 15 min of breakeast, at the moment of start of breakfast (0 min), and then 30, 60, 90, 120 min.
Plasma glucose levels, total/active GLP-1, ghrelin, total PYY will be measured.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 18.5~35 kg/m2
- Never diagnosed by diabetes
- Fasting plasma glucose <=100mg/dl and HbA1c <6.0%
Exclusion Criteria:
- Those who diagnosed by Type 1 or Type 2 diabetes
- Allergy to wheat, flour, nuts, milk
- Pregnancy/lactation
- AST or ALT >2.5 times of upper normal reference range
- eGFR <30 mL/min/1.73m2
- Hb <10g/dl
- History of GI surgery (except hemorrhoidectomy, appendectomy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1
protein enriched bar->commercial cereal bar->water
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
|
Experimental: Group 2
protein enriched bar->water->commercial cereal bar
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
|
Experimental: Group 3
commercial cereal bar->protein enriched bar->water
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
|
Experimental: Group 4
commercial cereal bar->water->protein enriched bar
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
|
Experimental: Group 5
water->protein enriched bar->commercial cereal bar
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
|
Experimental: Group 6
water->commercial cereal bar->protein enriched bar
|
Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Food intake
Time Frame: 120min
|
grams and caloric intake of standardized gimbap
|
120min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite (visual analogue scale : score 1 to 10)
Time Frame: 120min
|
(1: I am not hungry at all, 10: I have never been more hungry)
|
120min
|
|
Satiety (visual analogue scale : score 1 to 10)
Time Frame: 120min
|
120min
|
|
|
plasma glucose (mmol/L)
Time Frame: -15min, 0(breakfast), 30, 60, 90, 120 min
|
plasma level of glucose
|
-15min, 0(breakfast), 30, 60, 90, 120 min
|
|
plasma active/total GLP-1 (pmol/L)
Time Frame: -15min, 0(breakfast), 30, 60, 90, 120 min
|
plasma level of active/total GLP-1
|
-15min, 0(breakfast), 30, 60, 90, 120 min
|
|
plasma active ghrelin (ng/ml)
Time Frame: -15min, 0(breakfast), 30, 60, 90, 120 min
|
plasma level of active ghrelin
|
-15min, 0(breakfast), 30, 60, 90, 120 min
|
|
plasma total peptide YY (pg/ml)
Time Frame: -15min, 0(breakfast), 30, 60, 90, 120 min
|
plasma level of peptide YY
|
-15min, 0(breakfast), 30, 60, 90, 120 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Actual)
June 1, 2019
Study Completion (Actual)
June 1, 2019
Study Registration Dates
First Submitted
January 15, 2018
First Submitted That Met QC Criteria
February 6, 2018
First Posted (Actual)
February 13, 2018
Study Record Updates
Last Update Posted (Actual)
August 29, 2019
Last Update Submitted That Met QC Criteria
August 28, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- H-1705-091-855
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationCompletedAtopic Healthy Subjects | Adult Subjects With Allergic DiseasesKorea, Republic of
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Not yet recruitingHealthy Subjects
-
ZabBio Inc.Boston University; Eunice Kennedy Shriver National Institute of Child Health... and other collaboratorsRecruiting
-
NovoBliss Research Pvt LtdOneSto Labs Private Ltd.Not yet recruiting
Clinical Trials on Protein-enriched bar, commercial cereal bar, or water
-
Seoul National University HospitalCompletedPatients With Type 2 DiabetesKorea, Republic of
-
Seoul National University HospitalCompletedDiabetes MellitusKorea, Republic of